InvestorsHub Logo
Followers 30
Posts 2792
Boards Moderated 3
Alias Born 10/24/2015

Re: jondoeuk post# 101

Friday, 07/30/2021 3:52:02 PM

Friday, July 30, 2021 3:52:02 PM

Post# of 259
They also have a number of collaboration, one of which is with Stride Bio, whose platform allows them to modify AAV surfaces which are no longer recognized by pre-existing neutralising antibodies, modify binding sites to alter the tissue specificity, and engineer capsids to enhance potency as well as transduction efficiency.

In addition, they have in-licensed novel (AAV) vectors from Duke Uni and an IgG-degrading enzyme to clear neutralising antibodies https://insight.jci.org/articles/view/139881
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRSP News